ARCHIVES

FDA cancer therapeutics review split among three units in reorganization.

This article is from The Cancer Letter archive.

Vol. 29 No. 37 | October 10, 2003

Download PDF Visit The Full Archive

Related Articles

Leffall New ACS President, Gudberg, President-Elect

November 17, 1978

Vermont Cancer Center’s NCI Core Grant Renewed.

May 11, 2001

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

GM To Offer Three Awards of $1000,000 Each To Cancer Investigators

September 8, 1978

NIH Programs: Advisory Panel Formed On Cancer and Alternative Medicine

July 16, 1999

NCAB, Hammer Agree On how 41 Billion To Be Handled: No String Attached

October 14, 1988